This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

Strategic Advisory Board

The Bionow Strategic Advisory Board is composed of senior individuals from across the North of England representing a cross-section of our membership and the sector as a whole. The Advisory Board advises Bionow offering sector relevant stratgegic advice and guidance.

The current membership of the Strategic Advisory Board is as follows:

  • Chair: Mike Snowden, VP and Head of Discovery Science, AstraZeneca
  • Emma Banks, CEO, Datatrial
  • Graham Bond, Partner, RSM
  • Allan Brown, Chief Operating Officer, Epistem
  • Crawford Brown, Senior VP Biologics R&D, Allergan
  • Bob Burgoyne, Executive Pro-Vice-Chancellor, University of Liverpool
  • Keith Chantler, Director of Academic Affairs and Innovation, CMUH NHS Trust & Trustech
  • Chris Doherty, Alderley Park Site Director, MSP
  • Paul Found, COO, Fujifilm Diosynth Biotechnologies
  • John Goodacre, Faculty of Health and Medicine, Lancaster University
  • Andy Jones, VP Pharmaceutical Innovation, AstraZeneca
  • Kris Matykiewicz, Head of Business Engagement, University of Manchester
  • Neil Murray, CEO, Redx Pharma
  • Lloyd Payne, Executive Vice President, Evotec
  • Dave Simpson, CEO, Glythera
  • John Stageman, Chair, Bionow
  • Jane Theaker, Associate Director, QIAGEN
  • Simon Wallwork, Partner, Slater Heelis
About Us